Major drug manufacturers have already spent over $3 million lobbying the government to clamp down on copycat versions of weight-loss drugs, records show.
Novo Nordisk, the maker of Ozempic and Wegovy, has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of the drugs that have not been approved by the Federal Drug Administration, according to Politico.
